Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 11Colonic Neoplasms 7Breast Neoplasms 7Lung Neoplasms 6Brain Neoplasms 4Urinary Bladder Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Respiratory Aspiration 2Rectal Neoplasms 2Prostatic Neoplasms 2Postoperative Complications 2Pituitary Neoplasms 2Ovarian Neoplasms 2Neoplastic Cells, Circulating 2Neoplasm Metastasis 2Melanoma 2Uterine Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Recurrence 1Quality of Recovery 1Postoperative Cognitive Complications 1Pain, Postoperative 1Neurofibromatoses 1Myofibroma 1Liver Neoplasms 1Liver Functions Tests 1Intraoral Tumor 1Inflammation 1

Interventions

Propofol 2Dexmedetomidine 2contrast agent BR1 1Therapeutics 1Sevoflurane 1Ropivacaine 1Nitrous Oxide 1Lidocaine 1Iohexol 1Glycopyrrolate 1Food, Formulated 1FS 069 1Embolization, Therapeutic 1Drug Therapy 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Abdominal Neoplasms × Sevoflurane × Clear all
NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡